Subtyping Gastrointestinal Surgical Outcomes from Real World Data: A Comprehensive Analysis of UK Biobank.
Uri KartounKingsley NjokuTesfaye YadeteSivan RavidEileen KoskiWilliam OgalloJoao Bettencourt-SilvaNatasha MulliganJianying HuJulia LiuThaddeus StappenbeckVibha AnandPublished in: AMIA ... Annual Symposium proceedings. AMIA Symposium (2024)
Chronic gastrointestinal (GI) conditions, such as inflammatory bowel diseases (IBD), offer a promising opportunity to create classification systems that can enhance the accuracy of predicting the most effective therapies and prognosis for each patient. Here, we present a novel methodology to explore disease subtypes using our open-sourced BiomedSciAI toolkit. Applying methods available in this toolkit on the UK Biobank, including subpopulation-based feature selection and multi-dimensional subset scanning, we aimed to discover unique subgroups from GI surgery cohorts. Of a 12,073-patient cohort, a subgroup of 440 IBD patients was discovered with an increased risk of a subsequent GI surgery (OR: 2.21, 95% CI [1.81-2.69]). We iteratively demonstrate the discovery process using an additional cohort (with a narrower definition of GI surgery). Our results show that the iterative process can refine the subgroup discovery process and generate novel hypotheses to investigate determinants of treatment response.
Keyphrases
- minimally invasive
- coronary artery bypass
- end stage renal disease
- small molecule
- machine learning
- surgical site infection
- case report
- chronic kidney disease
- deep learning
- newly diagnosed
- high throughput
- ejection fraction
- cross sectional
- peritoneal dialysis
- prognostic factors
- clinical trial
- computed tomography
- high resolution
- big data
- phase iii
- patient reported outcomes
- acute coronary syndrome
- ulcerative colitis
- open label
- neural network
- dual energy